Featuring the world’s leading experts on this topic, Prof. Thomas Borody, Dr. William Chamberlin and Dr. Ira Shafran, this panel discusses antibiotic use in gastroenterology practice and answers audience questions.

Professor Thomas Borody is an Australian gastroenterologist who founded the Centre for Digestive Diseases in 1984 having trained at St Vincent’s in Sydney and the Mayo Clinic in the USA. He is best known for developing triple therapy cures such as Helidac and Pylera for peptic ulcers in 1984, which saved hundreds of thousands of lives, and later AMAT for Crohn’s and other diseases. As a practicing clinician, he has overseen since 1988 over 16,000 Fecal Microbiota Transplant procedures including the encapsulated format, creating a wealth of clinical data with potential to cure Crohn’s and UC.

Dr. William M. Chamberlin is a retired gastroenterologist who is currently conducting research into MAP. He served 20 years in the U.S. Army Medical Corps with his last assignment being at Walter Reed Army Institute of Research, where he studied the immune systems responses to microbial infections before settling into private practice. He has spoken throughout the world on topics such as The Role of Microbes in Crohn’s Disease, MAP, and on Crohn’s Disease as a disorder of autophagy.

Dr. Ira Shafran is a recently retired gastroenterologist who ran a busy practice in Winter Park, Florida since 1979. He graduated from the Ohio State University Medical School, and developed an exceptional clinical research program. His practice was 1 out of 17 centers nationally to receive the “Bridges to Excellence” recognition from the American Gastroenterology Association. As a leader in his field, Dr. Shafran lectures locally, nationally and internationally. He has been an outspoken advocate for patient rights.